We recently compiled a list of the 10 Pump and Dump Stocks Favored by Hedge Funds. In this article, we are going to take a ...

Arvinas, Inc. (ARVN) has been beaten down lately with too much selling pressure. While the stock has lost 54.9% over the past ...

Arvinas (ARVN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in ...

智通财经APP获悉，辉瑞公司(PFE.US)用于治疗乳腺癌的新一代药物Vepdegestrant在最终阶段的研究中取得了喜忧参半的结果，这可能对该公司曾称为潜在重磅药物的新药造成挫折。根据该公司周二发布的一份声明，名为Vepdegestrant的药物 ...

Charles Schwab Investment Management Inc. lifted its stake in shares of Arvinas, Inc. (NASDAQ:ARVN – Free Report) by 1.0% during the 4th quarter, according to its most recent disclosure with the ...

生物技术公司Arvinas Inc.(ARVN.US)将vepdegestrant授权给辉瑞，并有权分享利润。 Arvinas在纽约的盘前交易中股价下跌超过40%。而辉瑞的股价则几乎没有变化。

Arvinas (NASDAQ:ARVN – Get Free Report) was downgraded by analysts at Wedbush from an “outperform” rating to a “neutral” ...

Arvinas’ cash burn and lack of pipeline candidates hurt its outlook. See why ARVN stock is a sell, despite a healthy cash ...

$ARVN insiders have traded $ARVN stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales. Here’s a ...

Pfizer (NYSE:PFE) stock and Arvinas (NASDAQ:ARVN) stock slip in reaction to mixed Phase 3 data for their breast cancer drug ...

As previously reported, Wedbush analyst Robert Driscoll downgraded Arvinas (ARVN) to Neutral from Outperform with a price target of $12, down ...